[go: up one dir, main page]

FR2904221B1 - PHARMACEUTICAL COMPOSITION CONTAINING IN ASSOCIATION SAREDUTANT AND FLUOXETINE. - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING IN ASSOCIATION SAREDUTANT AND FLUOXETINE.

Info

Publication number
FR2904221B1
FR2904221B1 FR0607050A FR0607050A FR2904221B1 FR 2904221 B1 FR2904221 B1 FR 2904221B1 FR 0607050 A FR0607050 A FR 0607050A FR 0607050 A FR0607050 A FR 0607050A FR 2904221 B1 FR2904221 B1 FR 2904221B1
Authority
FR
France
Prior art keywords
saredutant
fluoxetine
association
pharmaceutical composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0607050A
Other languages
French (fr)
Other versions
FR2904221A1 (en
Inventor
Caroline Louis
Caroline Cohen
Guy Griebel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Priority to FR0607050A priority Critical patent/FR2904221B1/en
Priority to TW096126788A priority patent/TW200817003A/en
Priority to PE2007000979A priority patent/PE20080431A1/en
Priority to CNA2007800287391A priority patent/CN101495109A/en
Priority to EA200970167A priority patent/EA200970167A1/en
Priority to AU2007283530A priority patent/AU2007283530A1/en
Priority to MX2009001219A priority patent/MX2009001219A/en
Priority to CL200702217A priority patent/CL2007002217A1/en
Priority to JP2009522301A priority patent/JP2009545573A/en
Priority to CA002658614A priority patent/CA2658614A1/en
Priority to PCT/FR2007/001314 priority patent/WO2008017753A2/en
Priority to KR1020097002031A priority patent/KR20090034368A/en
Priority to ARP070103357A priority patent/AR062142A1/en
Priority to EP07823369A priority patent/EP2049093A2/en
Priority to BRPI0714862-3A priority patent/BRPI0714862A2/en
Priority to US11/830,325 priority patent/US20080033014A1/en
Priority to UY30517A priority patent/UY30517A1/en
Publication of FR2904221A1 publication Critical patent/FR2904221A1/en
Application granted granted Critical
Publication of FR2904221B1 publication Critical patent/FR2904221B1/en
Priority to TN2009000008A priority patent/TN2009000008A1/en
Priority to IL196570A priority patent/IL196570A0/en
Priority to CR10579A priority patent/CR10579A/en
Priority to EC2009009093A priority patent/ECSP099093A/en
Priority to CO09007492A priority patent/CO6150152A2/en
Priority to MA31638A priority patent/MA30645B1/en
Priority to NO20090924A priority patent/NO20090924L/en
Priority to US12/469,215 priority patent/US20090227632A1/en
Priority to GT200900018A priority patent/GT200900018A/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0607050A 2006-02-07 2006-07-31 PHARMACEUTICAL COMPOSITION CONTAINING IN ASSOCIATION SAREDUTANT AND FLUOXETINE. Expired - Fee Related FR2904221B1 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
FR0607050A FR2904221B1 (en) 2006-07-31 2006-07-31 PHARMACEUTICAL COMPOSITION CONTAINING IN ASSOCIATION SAREDUTANT AND FLUOXETINE.
TW096126788A TW200817003A (en) 2006-07-31 2007-07-23 Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
PE2007000979A PE20080431A1 (en) 2006-07-31 2007-07-26 PHARMACEUTICAL COMPOSITION CONTAINING ASSOCIATION SAREDUTANT AND A SELECTIVE INHIBITOR OF SEROTONIN RECAPTATION OR AN INHIBITOR OF SEROTONIN / NOREPINEPHRINE RECAPTATION
US11/830,325 US20080033014A1 (en) 2006-02-07 2007-07-30 Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin reuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
AU2007283530A AU2007283530A1 (en) 2006-07-31 2007-07-30 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination
MX2009001219A MX2009001219A (en) 2006-07-31 2007-07-30 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination.
CL200702217A CL2007002217A1 (en) 2006-07-31 2007-07-30 PHARMACEUTICAL COMPOSITION CONTAINING SAREDUTANT WITH A SELECTIVE INHIBITOR OF SEROTONIN RECAPTATION OR WITH AN INHIBITOR OF SEROTONIN / NOREPINEFRINE RECAPTATION; AND USE IN THE PREVENTION AND TREATMENT OF A MAJOR DEPRESSIVE DISORDER.
JP2009522301A JP2009545573A (en) 2006-07-31 2007-07-30 A pharmaceutical composition comprising a combination of saletutant and a selective inhibitor of serotonin reuptake or an inhibitor of serotonin / norepinephrine reuptake
CA002658614A CA2658614A1 (en) 2006-07-31 2007-07-30 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination
PCT/FR2007/001314 WO2008017753A2 (en) 2006-07-31 2007-07-30 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination
KR1020097002031A KR20090034368A (en) 2006-07-31 2007-07-30 Pharmaceutical compositions containing a combination of saredutant and selective serotonin reuptake inhibitors or serotonin / norepinephrine reuptake inhibitors
ARP070103357A AR062142A1 (en) 2006-07-31 2007-07-30 PHARMACEUTICAL COMPOSITION CONTAINING IN SAREDUTANT ASSOCIATION AND A SELECTIVE INHIBITOR OF SEROTONINE RECOVERY OR AN INHIBITOR OF SEROTONIN / NOREPINEFRINE RECOVERY
EP07823369A EP2049093A2 (en) 2006-07-31 2007-07-30 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination
BRPI0714862-3A BRPI0714862A2 (en) 2006-07-31 2007-07-30 pharmaceutical composition containing saredutant and a selective serotonin reuptake inhibitor or a serotonin / norepinephrine reuptake inhibitor
CNA2007800287391A CN101495109A (en) 2006-07-31 2007-07-30 Pharmaceutical composition comprising a combination of saredutant and a selective inhibitor of the reuptake of 5-hydroxytryptamine or an inhibitor of the reuptake of 5-hydroxytryptamine/norepinephrine
EA200970167A EA200970167A1 (en) 2006-07-31 2007-07-30 A PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF A SARADUTANT AND A SELECTIVE INHIBITOR OF REVERSE CAPTURE OF SEROTONIN OR A SERIAL TONINO REQUIRED CAPTURE INHIBITOR / NOREPINEFRIN INHIBITOR
UY30517A UY30517A1 (en) 2006-07-31 2007-07-31 PHARMACEUTICAL COMPOSITION CONTAINING IN ASSOCIATION SAREDUTANT AND A SELECTIVE INHIBITOR OF THE RECOVERY OF SEROTONINE OR AN INHIBITOR OF THE RECOVERY OF SEROTONINE / NOREPINEFRINE
TN2009000008A TN2009000008A1 (en) 2006-07-31 2009-01-14 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination
IL196570A IL196570A0 (en) 2006-07-31 2009-01-18 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination
CR10579A CR10579A (en) 2006-07-31 2009-01-21 PHARMACEUTICAL COMPOSITION CONTAINING IN SAREDUTANT ASSOCIATION AND A SELECTIVE INHIBITOR OF SEROTONINE RECOVERY OR AN INHIBITOR OF SEROTONIN / NOREPINEFRINE RECOVERY
EC2009009093A ECSP099093A (en) 2006-07-31 2009-01-27 PHARMACEUTICAL COMPOSITION CONTAINING IN SAREDUTANT ASSOCIATION AND A SELECTIVE INHIBITOR OF SEROTONINE RECOVERY OR AN INHIBITOR OF SEROTONIN / NOREPINEFRINE RECOVERY
CO09007492A CO6150152A2 (en) 2006-07-31 2009-01-28 PHARMACEUTICAL COMPOSITION
MA31638A MA30645B1 (en) 2006-07-31 2009-02-13 PHARMACEUTICAL COMPOSITION COMPRISING SAREDUTANT AND A SELECTIVE SEROTONIN RECAPTURE INHIBITOR OR SEROTONIN / NOREPINEPHRINE RECAPTURE INHIBITOR
NO20090924A NO20090924L (en) 2006-07-31 2009-02-27 Pharmaceutical compound containing saredutant and a selective inhibitor of serotonin reuptake or an inhibitor of serotonin / norepinephrine reuptake in combination
US12/469,215 US20090227632A1 (en) 2006-07-31 2009-05-20 Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin reuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
GT200900018A GT200900018A (en) 2006-07-31 2009-07-31 PHARMACEUTICAL COMPOSITION CONTAINING IN ASSOCIATION SAREDUTANT AND A SELECTIVE INHIBITOR OF THE RECOVERY OF SEROTONINE OR A UNHIBITOR OF THE RECOVERY OF SEROTONINE / NOREPINEFRINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0607050A FR2904221B1 (en) 2006-07-31 2006-07-31 PHARMACEUTICAL COMPOSITION CONTAINING IN ASSOCIATION SAREDUTANT AND FLUOXETINE.

Publications (2)

Publication Number Publication Date
FR2904221A1 FR2904221A1 (en) 2008-02-01
FR2904221B1 true FR2904221B1 (en) 2008-09-12

Family

ID=37776830

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0607050A Expired - Fee Related FR2904221B1 (en) 2006-02-07 2006-07-31 PHARMACEUTICAL COMPOSITION CONTAINING IN ASSOCIATION SAREDUTANT AND FLUOXETINE.

Country Status (2)

Country Link
CN (1) CN101495109A (en)
FR (1) FR2904221B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104666291A (en) * 2013-11-26 2015-06-03 山东绿叶制药有限公司 Application of O-desmethylvenlafaxine benzoate compound in preparation of medicines for improving sexual dysfunction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792835B3 (en) * 1999-04-27 2001-05-25 Sanofi Sa USE OF SAREDUTANT FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OR PREVENTION OF ALL MOOD DISORDERS, ADAPTATION DISORDERS OR MIXED ANXIETY-DEPRESSION DISORDERS

Also Published As

Publication number Publication date
CN101495109A (en) 2009-07-29
FR2904221A1 (en) 2008-02-01

Similar Documents

Publication Publication Date Title
EP1861387A4 (en) NOVEL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
EP2100610A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING LOW SUBSTITUTED HYDROXYPROPYLCELLULOSE
EP1980320A4 (en) PHOTOCATALYST MATERIAL AND PHOTOCATALYST COMPOSITION AND PHOTOCATALYST PRODUCT CONTAINING SAME
EP2186889A4 (en) CDCA1 PEPTIDE AND PHARMACEUTICAL AGENT COMPRISING SAME
EP1912679A4 (en) LIPIDS CONTAINING AMINES AND USES
EP1849470A4 (en) ANTICANCER DRUGS CONTAINING ALPHA, ALPHA, ALPHA-TRIFLUOROTHYMIDINE AND A THYMIDINE PHOSPHORYLASE INHIBITOR
EP2066785A4 (en) BACTERIAL CULTURES AND COMPOSITIONS CONTAINING BACTERIAL CULTURES
FR2897664B1 (en) SEAL PACKINGS AND METHOD OF USE.
EP2098227A4 (en) NON-CARIOUS MATERIAL AND ANTI-CARRY AGENT CONTAINING RARE SUGAR
FR18C1032I2 (en) ANTI-FGF23 ANTIBODIES AND PHARMACEUTICAL COMPOSITION COMPRISING IT
EP2484697A4 (en) ANTIPODOPLANIN ANTIBODY AND PHARMACEUTICAL COMPOSITION CONTAINING ANTIPODOPLANIN ANTIBODY
EP2334201A4 (en) FRAGRANCE AND AROMATIC MATERIALS CONTAINING THIOL
EP1997496A4 (en) COMPOSITION CONTAINING RIBOFLAVIN AND SESAMINES
EP2475649A4 (en) INDENONIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
EP2358702A4 (en) PIPERIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF
FR2949782B1 (en) TRANSGLUTAMINASE ACTIVATOR PEPTIDE AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING SAME.
EP1935942A4 (en) MASTER MIXTURE AND COMPOSITION CONTAINING SAID MASTER MIXTURE
BRPI0720684A2 (en) compound, drug, pharmaceutical composition containing and use of compound
EP1867332A4 (en) PHARMACEUTICAL COMPOSITION AND METHOD FOR USING AN ANONGONGIC AGENT IN COMBINATION
EP1819323A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-NUCLEATION AGENT
FR2870539B1 (en) NEW METHODS AND MEDICINES
EP1937255A4 (en) PHARMACEUTICAL COMPOSITION
EP2263671A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN AMIDE DERIVATIVE
EP2233467A4 (en) ALPHA-AMINO N-SUBSTITUTED AMIDES, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USES THEREOF
EP2086524A4 (en) TRANSNASAL ANTICONVULSIVE PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130329